Vadadustat Matches Standard for CKD-Related Anemia, With Caveat

(MedPage Today) -- The investigational hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor vadadustat was noninferior to the erythropoiesis-stimulating agent darbepoetin alfa for treating anemia in chronic kidney disease (CKD) patients...